Lowering the dietary omega-6: Omega-3 does not hinder nonalcoholic fatty-liver disease development in a murine model

Nutrition Research

Volumn 35, Issue 5, 2015, Pages 449-459

  Enos, Reilly T ^a   Velázquez, Kandy T ^a   McClellan, Jamie L ^a   Cranford, Taryn L ^a   Walla, Michael D ^b   Murphy, E Angela ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Colitis; High fat diet; Murine model; Nonalcoholic fatty liver disease; Omega 6:omega 3; Linolenic acid

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; OCCLUDIN; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PROTEIN ZO1; AUTACOID; PHOSPHOLIPID; TIGHT JUNCTION PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; CONTROLLED STUDY; ENDOPLASMIC RETICULUM STRESS; GENE EXPRESSION; INFLAMMATION; LIPID DIET; LIVER LEVEL; LIVER METABOLISM; LOW FAT DIET; MACROPHAGE; MALE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; THERAPY EFFECT; ADVERSE EFFECTS; ANIMAL; C57BL MOUSE; CHEMISTRY; COLON; COMPARATIVE STUDY; DISEASE COURSE; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; INTESTINE MUCOSA; LIVER; METABOLISM; NON-ALCOHOLIC FATTY LIVER DISEASE; PATHOLOGY; PATHOPHYSIOLOGY; RANDOMIZATION; WESTERN DIET;

MURINAE; MUS;

ANIMALS; ARACHIDONIC ACID; COLITIS; COLON; DIET, FAT-RESTRICTED; DIET, WESTERN; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ENDOPLASMIC RETICULUM STRESS; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; GENE EXPRESSION REGULATION; INFLAMMATION MEDIATORS; INTESTINAL MUCOSA; LIVER; MALE; MICE, INBRED C57BL; NON-ALCOHOLIC FATTY LIVER DISEASE; OXIDATIVE STRESS; PHOSPHOLIPIDS; RANDOM ALLOCATION; TIGHT JUNCTION PROTEINS;

EID: 84930004870     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2015.04.003     Document Type: Article

References (46)

1. Vernon G., Baranova A., Younossi Z.M. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 2011, 34:274-285.
2. Chalasani N., Younossi Z., Lavine J.E., Diehl A.M., Brunt E.M., Cusi K., et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology 2012, 142:1592-1609.
3. Leamy A.K., Egnatchik R.A., Young J.D. Molecular mechanisms and the role of saturated fatty acids in the progression of non-alcoholic fatty liver disease. Prog Lipid Res 2013 Jan, 52(1):165-174.
4. Yeh M.M., Brunt E.M. Pathological features of fatty liver disease. Gastroenterology 2014, 147:754-764.
5. Chassaing B., Etienne-Mesmin L., Gewirtz A.T. Microbiota-liver axis in hepatic disease. Hepatology 2014, 59:328-339.
6. Kim K.A., Gu W., Lee I.A., Joh E.H., Kim D.H. High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway. PLoS One 2012, 7:e47713.
7. Asrih M., Jornayvaz F.R. Diets and nonalcoholic fatty liver disease: the good and the bad. Clin Nutr 2014, 33:186-190.
8. Ronis M.J., Baumgardner J.N., Sharma N., Vantrease J., Ferguson M., Tong Y., et al. Medium chain triglycerides dose-dependently prevent liver pathology in a rat model of non-alcoholic fatty liver disease. Exp Biol Med (Maywood) 2013, 238:151-162.
9. Scorletti E., Byrne C.D. Omega-3 fatty acids, hepatic lipid metabolism, and nonalcoholic fatty liver disease. Annu Rev Nutr 2013, 33:231-248.
10. Elizondo A., Araya J., Rodrigo R., Poniachik J., Csendes A., Maluenda F., et al. Polyunsaturated fatty acid pattern in liver and erythrocyte phospholipids from obese patients. Obesity (Silver Spring) 2007, 15:24-31.
11. Parker H.M., Johnson N.A., Burdon C.A., Cohn J.S., O'Connor H.T., George J. Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis. J Hepatol 2012, 56:944-951.
12. Di Minno M.N., Russolillo A., Lupoli R., Ambrosino P., Di Minno A., Tarantino G. Omega-3 fatty acids for the treatment of non-alcoholic fatty liver disease. World J Gastroenterol 2012, 18:5839-5847.
13. Valenzuela R., Espinosa A., Gonzalez-Manan D., D'Espessailles A., Fernandez V., Videla L.A., et al. N-3 long-chain polyunsaturated fatty acid supplementation significantly reduces liver oxidative stress in high fat induced steatosis. PLoS One 2012, 7:e46400.
14. Enos R.T., Velazquez K.T., McClellan J.L., Cranford T.L., Walla M.D., Murphy E.A. Reducing the dietary omega-6:omega-3 utilizing alpha-linolenic acid; not a sufficient therapy for attenuating high-fat-diet-induced obesity development nor related detrimental metabolic and adipose tissue inflammatory outcomes. PLoS One 2014, 9:e94897.
15. Kim W., McMurray D.N., Chapkin R.S. n-3 polyunsaturated fatty acids-physiological relevance of dose. Prostaglandins Leukot Essent Fatty Acids 2010, 82:155-158.
16. Simopoulos A.P. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med (Maywood) 2008, 233:674-688.
17. Grotto D., Zied E. The Standard American Diet and its relationship to the health status of Americans. Nutr Clin Pract 2010, 25:603-612.
18. Center for Disease Control and Prevention National Health and Nutrition Examination Survey data 2011-2012, U.S. Department of Health and Human Services, Hyattsville, MD.
19. Archer E., Hand G.A., Blair S.N. Validity of U.S. nutritional surveillance: National Health and Nutrition Examination Survey caloric energy intake data, 1971-2010. PLoS One 2013, 8:e76632.
20. Goris A.H., Westerterp-Plantenga M.S., Westerterp K.R. Undereating and underrecording of habitual food intake in obese men: selective underreporting of fat intake. Am J Clin Nutr 2000, 71:130-134.
21. Scagliusi F.B., Polacow V.O., Artioli G.G., Benatti F.B., Lancha A.H. Selective underreporting of energy intake in women: magnitude, determinants, and effect of training. J Am Diet Assoc 2003, 103:1306-1313.
22. Lissner L., Heitmann B.L., Bengtsson C. Population studies of diet and obesity. Br J Nutr 2000, 83(Suppl. 1):S21-S24.
23. Heitmann B.L., Lissner L., Osler M. Do we eat less fat, or just report so?. Int J Obes Relat Metab Disord 2000, 24:435-442.
24. Enos R.T., Velazquez K.T., Murphy E.A. Insight into the impact of dietary saturated fat on tissue-specific cellular processes underlying obesity-related diseases. J Nutr Biochem 2014, 25:600-612.
25. Velazquez K.T., Enos R.T., Narsale A.A., Puppa M.J., Davis J.M., Murphy E.A., et al. Quercetin supplementation attenuates the progression of cancer cachexia in ApcMin/+ mice. J Nutr 2014 Jun, 144(6):868-875.
26. Enos R.T., Davis J.M., Velazquez K.T., McClellan J.L., Day S.D., Carnevale K.A., et al. Influence of dietary saturated fat content on adiposity, macrophage behavior, inflammation, and metabolism: composition matters. J Lipid Res 2013, 54:152-163.
27. Folch J., Lees M., Sloane Stanley G.H. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957, 226:497-509.
28. Saunders R.D., Horrocks L.A. Simultaneous extraction and preparation for high-performance liquid chromatography of prostaglandins and phospholipids. Anal Biochem 1984, 143:71-75.
29. Nakashima H., Ogawa Y., Shono S., Kinoshita M., Nakashima M., Sato A., et al. Activation of CD11b + Kupffer cells/macrophages as a common cause for exacerbation of TNF/Fas-ligand-dependent hepatitis in hypercholesterolemic mice. PLoS One 2013, 8:e49339.
30. Smith K. Liver disease: Kupffer cells regulate the progression of ALD and NAFLD. Nat Rev Gastroenterol Hepatol 2013 Sep, 10(9):503.
31. Corrado R.L., Torres D.M., Harrison S.A. Review of treatment options for nonalcoholic fatty liver disease. Med Clin North Am 2014, 98:55-72.
32. Simopoulos A.P. Importance of the omega-6/omega-3 balance in health and disease: evolutionary aspects of diet. World Rev Nutr Diet 2011, 102:10-21.
33. Wall R., Ross R.P., Fitzgerald G.F., Stanton C. Fatty acids from fish: the anti-inflammatory potential of long-chain omega-3 fatty acids. Nutr Rev 2010, 68:280-289.
34. Yan F., Wang Q., Xu C., Cao M., Zhou X., Wang T., et al. Peroxisome proliferator-activated receptor alpha activation induces hepatic steatosis, suggesting an adverse effect. PLoS One 2014, 9:e99245.
35. Covarrubias A.J., Horng T. IL-6 strikes a balance in metabolic inflammation. Cell Metab 2014, 19:898-899.
36. Oh D.Y., Talukdar S., Bae E.J., Imamura T., Morinaga H., Fan W., et al. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 2010, 142:687-698.
37. Takaki A., Kawai D., Yamamoto K. Multiple hits, including oxidative stress, as pathogenesis and treatment target in non-alcoholic steatohepatitis (NASH). Int J Mol Sci 2014, 14:20704-20728.
38. Ucar F., Sezer S., Erdogan S., Akyol S., Armutcu F., Akyol O. The relationship between oxidative stress and nonalcoholic fatty liver disease: its effects on the development of nonalcoholic steatohepatitis. Redox Rep 2013, 18:127-133.
39. Mattson M.P. Roles of the lipid peroxidation product 4-hydroxynonenal in obesity, the metabolic syndrome, and associated vascular and neurodegenerative disorders. Exp Gerontol 2009, 44:625-633.
40. Pagliassotti M.J. Endoplasmic reticulum stress in nonalcoholic fatty liver disease. Annu Rev Nutr 2012, 32:17-33.
41. Zhao M., Zang B., Cheng M., Ma Y., Yang Y., Yang N. Differential responses of hepatic endoplasmic reticulum stress and inflammation in diet-induced obese rats with high-fat diet rich in lard oil or soybean oil. PLoS One 2013, 8:e78620.
42. Chambers J.E., Marciniak S.J. Protein misfolding and ER stress. Am J Physiol Cell Physiol 2014 Oct 15, 307(8):C657-C670.
43. Coelho D.S., Domingos P.M. Physiological roles of regulated Ire1 dependent decay. Front Genet 2014 Apr 16, 5:76.
44. Tillander V., Bjorndal B., Burri L., Bohov P., Skorve J., Berge R.K., et al. Fish oil and krill oil supplementations differentially regulate lipid catabolic and synthetic pathways in mice. Nutr Metab (Lond) 2014, 11:20.
45. Riediger N.D., Othman R., Fitz E., Pierce G.N., Suh M., Moghadasian M.H. Low n-6:n-3 fatty acid ratio, with fish- or flaxseed oil, in a high fat diet improves plasma lipids and beneficially alters tissue fatty acid composition in mice. Eur J Nutr 2008, 47:153-160.
46. Pachikian B.D., Essaghir A., Demoulin J.B., Neyrinck A.M., Catry E., De Backer F.C., et al. Hepatic n-3 polyunsaturated fatty acid depletion promotes steatosis and insulin resistance in mice: genomic analysis of cellular targets. PLoS One 2011, 6:e23365.